|
FANCM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.0183999976654E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.26480000495999E-08 |
| Normal-vs-Stage2 |
8.17610000036773E-07 |
| Normal-vs-Stage3 |
3.9718994759852E-10 |
| Normal-vs-Stage4 |
2.87250001562711E-10 |
| Stage1-vs-Stage2 |
5.274200E-01 |
| Stage1-vs-Stage3 |
1.302550E-01 |
| Stage1-vs-Stage4 |
6.262300E-03 |
| Stage2-vs-Stage3 |
6.607200E-01 |
| Stage2-vs-Stage4 |
1.597590E-01 |
| Stage3-vs-Stage4 |
2.441000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.74659999796489E-08 |
| Normal-vs-AfricanAmerican |
5.016700E-04 |
| Normal-vs-Asian |
2.0140999999918E-05 |
| Caucasian-vs-AfricanAmerican |
6.023400E-01 |
| Caucasian-vs-Asian |
5.013400E-01 |
| AfricanAmerican-vs-Asian |
9.907200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.41399999989511E-09 |
| Normal-vs-Female |
2.92189999973047E-08 |
| Male-vs-Female |
1.517210E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.47800000033827E-07 |
| Normal-vs-Age(41-60Yrs) |
1.55540025303935E-11 |
| Normal-vs-Age(61-80Yrs) |
1.08950004573671E-09 |
| Normal-vs-Age(81-100Yrs) |
1.241670E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.952000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.623700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.377380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.903400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.954800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.304600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.673590E-01 |
| Classical-VS-Follicular |
9.037500E-03 |
| Classical-VS-Other |
3.070200E-01 |
| Classical-VS-Normal |
4.13700000034822E-07 |
| Tall-VS-Follicular |
7.681400E-01 |
| Tall-VS-Other |
7.371000E-01 |
| Tall-VS-Normal |
2.45379999985751E-07 |
| Follicular-VS-Other |
8.839800E-01 |
| Follicular-VS-Normal |
2.59499999266666E-09 |
| Other-VS-Normal |
4.577100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.07780004313207E-09 |
| Normal-vs-N1 |
2.99969999950633E-07 |
| N0-vs-N1 |
7.073000E-01 |
|
|
